Quinestradol: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''Quinestradol''' is a | {{Short description|Synthetic estrogen}} | ||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477241123 | |||
| IUPAC_name = (8R,9S,13S,14S,17S)-13-methyl-3-phenyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | |||
| image = Quinestradiol_structure.png | |||
| image2 = Quinestradiol_structure.png | |||
}} | |||
'''Quinestradol''' is a synthetic [[estrogen]] that was developed for medical use. It is a derivative of [[estradiol]], the primary female sex hormone, and is used in [[hormone replacement therapy]] and other estrogen-related treatments. | |||
==Chemical Structure== | |||
[[File:Quinestradiol_structure.png|thumb|right|Chemical structure of Quinestradiol]] | |||
Quinestradol is a [[steroid]]al estrogen, meaning it is based on the steroid structure of estradiol. It is chemically known as 3-cyclopentyl ether of estradiol. The presence of the cyclopentyl group in its structure makes it a unique compound among estrogens. | |||
==Pharmacology== | ==Pharmacology== | ||
Quinestradol | Quinestradol acts as an agonist of the [[estrogen receptor]], which is the biological target of estrogens like estradiol. By binding to these receptors, quinestradol mimics the effects of natural estrogens in the body, influencing the development and maintenance of female reproductive tissues and secondary sexual characteristics. | ||
==Medical | ==Medical Uses== | ||
Quinestradol | Quinestradol has been used in the treatment of menopausal symptoms, such as [[hot flashes]], [[vaginal atrophy]], and [[osteoporosis]]. It is also used in [[hormone replacement therapy]] for women who have undergone [[oophorectomy]] or have [[hypoestrogenism]]. | ||
==Side | ==Administration== | ||
As with | Quinestradol is typically administered orally. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to the therapy. | ||
==Side Effects== | |||
As with other estrogens, quinestradol can cause side effects such as [[nausea]], [[breast tenderness]], [[headache]], and [[fluid retention]]. Long-term use of estrogens has been associated with an increased risk of [[breast cancer]] and [[endometrial cancer]]. | |||
==Related Compounds== | |||
Quinestradol is related to other synthetic estrogens such as [[ethinylestradiol]] and [[mestranol]]. These compounds are also used in various hormonal therapies and [[oral contraceptives]]. | |||
==History== | ==History== | ||
Quinestradol was | Quinestradol was developed in the mid-20th century as part of efforts to create effective synthetic estrogens for therapeutic use. It was one of several compounds explored for its potential benefits in hormone therapy. | ||
==See | ==See Also== | ||
* [[Estradiol]] | * [[Estradiol]] | ||
* [[Hormone replacement therapy]] | * [[Hormone replacement therapy]] | ||
* [[Estrogen receptor]] | |||
==Related Pages== | |||
* [[Estrogen]] | |||
* [[Steroid hormone]] | |||
* [[Menopause]] | * [[Menopause]] | ||
[[Category: | [[Category:Synthetic estrogens]] | ||
[[Category: | [[Category:Steroidal estrogens]] | ||
Latest revision as of 11:07, 23 March 2025
Synthetic estrogen
| Quinestradol | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Quinestradol is a synthetic estrogen that was developed for medical use. It is a derivative of estradiol, the primary female sex hormone, and is used in hormone replacement therapy and other estrogen-related treatments.
Chemical Structure[edit]
Quinestradol is a steroidal estrogen, meaning it is based on the steroid structure of estradiol. It is chemically known as 3-cyclopentyl ether of estradiol. The presence of the cyclopentyl group in its structure makes it a unique compound among estrogens.
Pharmacology[edit]
Quinestradol acts as an agonist of the estrogen receptor, which is the biological target of estrogens like estradiol. By binding to these receptors, quinestradol mimics the effects of natural estrogens in the body, influencing the development and maintenance of female reproductive tissues and secondary sexual characteristics.
Medical Uses[edit]
Quinestradol has been used in the treatment of menopausal symptoms, such as hot flashes, vaginal atrophy, and osteoporosis. It is also used in hormone replacement therapy for women who have undergone oophorectomy or have hypoestrogenism.
Administration[edit]
Quinestradol is typically administered orally. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to the therapy.
Side Effects[edit]
As with other estrogens, quinestradol can cause side effects such as nausea, breast tenderness, headache, and fluid retention. Long-term use of estrogens has been associated with an increased risk of breast cancer and endometrial cancer.
Related Compounds[edit]
Quinestradol is related to other synthetic estrogens such as ethinylestradiol and mestranol. These compounds are also used in various hormonal therapies and oral contraceptives.
History[edit]
Quinestradol was developed in the mid-20th century as part of efforts to create effective synthetic estrogens for therapeutic use. It was one of several compounds explored for its potential benefits in hormone therapy.
